ATE12791T1 - Kurzkettige oligosaccharide mit biologischen eigenschaften, verfahren zu ihrer herstellung und ihre verwendungen als arzneimittel. - Google Patents

Kurzkettige oligosaccharide mit biologischen eigenschaften, verfahren zu ihrer herstellung und ihre verwendungen als arzneimittel.

Info

Publication number
ATE12791T1
ATE12791T1 AT82400739T AT82400739T ATE12791T1 AT E12791 T1 ATE12791 T1 AT E12791T1 AT 82400739 T AT82400739 T AT 82400739T AT 82400739 T AT82400739 T AT 82400739T AT E12791 T1 ATE12791 T1 AT E12791T1
Authority
AT
Austria
Prior art keywords
octasaccharides
abreviation
see diagramm
denoted below
sequence
Prior art date
Application number
AT82400739T
Other languages
English (en)
Inventor
Jean-Claude Lormeau
Jean Choay
Maurice Petitou
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay Sa filed Critical Choay Sa
Application granted granted Critical
Publication of ATE12791T1 publication Critical patent/ATE12791T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y402/00Carbon-oxygen lyases (4.2)
    • C12Y402/02Carbon-oxygen lyases (4.2) acting on polysaccharides (4.2.2)
    • C12Y402/02007Heparin lyase (4.2.2.7), i.e. heparinase I

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT82400739T 1981-04-29 1982-04-26 Kurzkettige oligosaccharide mit biologischen eigenschaften, verfahren zu ihrer herstellung und ihre verwendungen als arzneimittel. ATE12791T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8108604A FR2504928A1 (fr) 1981-04-29 1981-04-29 Oligosaccharides a chaines courtes possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments
EP82400739A EP0064452B1 (de) 1981-04-29 1982-04-26 Kurzkettige Oligosaccharide mit biologischen Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendungen als Arzneimittel

Publications (1)

Publication Number Publication Date
ATE12791T1 true ATE12791T1 (de) 1985-05-15

Family

ID=9257922

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82400739T ATE12791T1 (de) 1981-04-29 1982-04-26 Kurzkettige oligosaccharide mit biologischen eigenschaften, verfahren zu ihrer herstellung und ihre verwendungen als arzneimittel.

Country Status (9)

Country Link
EP (1) EP0064452B1 (de)
JP (1) JPS57190001A (de)
AT (1) ATE12791T1 (de)
CA (1) CA1180292A (de)
DE (1) DE3263083D1 (de)
DK (1) DK189982A (de)
ES (1) ES511470A0 (de)
FR (1) FR2504928A1 (de)
IE (1) IE52906B1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
EP0209924A1 (de) * 1985-07-12 1987-01-28 Akzo N.V. Antithrombotikum auf Basis von Glykosaminoglykan, Verfahren zu dessen Herstellung und pharmazeutische Zusammensetzung
US5106734A (en) * 1986-04-30 1992-04-21 Novo Nordisk A/S Process of using light absorption to control enzymatic depolymerization of heparin to produce low molecular weight heparin
US5707973A (en) * 1991-04-23 1998-01-13 Rhone-Poulenc Rorer S.A. Sulfated polysaccharids for treatment or prevention of thromboses
EP0861903A1 (de) * 1997-02-22 1998-09-02 Lansing, Manfred Verfahren zum reversiblen Immobilisieren von Oligo- oder Polysacchariden
US5985582A (en) * 1997-12-09 1999-11-16 Sigma-Aldrich Co. Thrombin-based assay for antithrombin III
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
EP1582531A1 (de) 2004-03-24 2005-10-05 Aventis Pharma S.A. Verfahren zur Oxydierung nicht-fraktionierten Heparins und die Detektion der Anwesenheit oder Abwesenheit von Glykoserin in Heparin und in von Heparin abgeleiteten Produkten
EP1792621B1 (de) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Oral verabreichbare Heparinderivate
WO2009155108A1 (en) 2008-05-30 2009-12-23 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
EP3398971A4 (de) * 2015-12-30 2019-09-25 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Sulfatiertes heparinoligosaccharid und herstellungsverfahren und anwendung davon
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
JP2022540849A (ja) 2019-07-09 2022-09-20 オプティムヴィア、エルエルシー 抗凝固性多糖類の合成方法
JP7611465B2 (ja) * 2019-10-10 2025-01-10 ジェイ・アイ・サイエンス有限会社 溶離液性の利用フラクションコレクター

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766167A (en) * 1971-03-26 1973-10-16 Research Corp Orally active anticoagulant
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
JPH0231721A (ja) * 1988-07-20 1990-02-01 Matsushita Electric Ind Co Ltd 充電式掃除機

Also Published As

Publication number Publication date
EP0064452A1 (de) 1982-11-10
ES8302094A1 (es) 1983-02-01
EP0064452B1 (de) 1985-04-17
CA1180292A (en) 1985-01-02
IE820741L (en) 1982-10-29
ES511470A0 (es) 1983-02-01
DE3263083D1 (en) 1985-05-23
FR2504928B1 (de) 1984-02-24
JPS57190001A (en) 1982-11-22
DK189982A (da) 1982-10-30
IE52906B1 (en) 1988-04-13
FR2504928A1 (fr) 1982-11-05

Similar Documents

Publication Publication Date Title
ATE12791T1 (de) Kurzkettige oligosaccharide mit biologischen eigenschaften, verfahren zu ihrer herstellung und ihre verwendungen als arzneimittel.
AU627207B2 (en) Pharmaceutical composition comprising protein kinase c inhibitor and anti-cancer agent
CA2069961A1 (en) Method and compositions for inhibition of disorders associated with oxidative damage
MA26720A1 (fr) Composes nouveaux inhibiteurs de reabsorption de monoamines, procede pour leur preparation, et compositions pharmaceutiques les contenant.
HU9401445D0 (en) Nor-bile-acid derivatives, process for producing them and pharmaceutical compositions containing them
ATE20518T1 (de) Trockene pulverige allergenzusammensetzung und verfahren zu deren herstellung.
ATE534656T1 (de) Neue oligosaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
PT85591A (en) Process for the preparation of multiple unit dosage pharmaceutical compositions comprising as a pharmaceutilly active compound l-dopa
DE69431035T2 (de) 2-Phenyl-3-Azoylbenzothiophene zur Erhöhung der Thrombomodulin Expression
ATE82681T1 (de) 2',3'-dideoxy-3'-fluorothymidin und verwandte verbindungen zur behandlung von adenovirusinfektionen.
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
DE69520675T2 (de) Verfahren zur anzeige der neutralisation von desinfektionslösungen für kontaktlinsen
NO20011091D0 (no) Umettede hydroksiminsyrederivater som PARP inhibitorer
EP0913396A3 (de) Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
NO753674L (de)
BR0109617A (pt) Composição farmacêutica, oligossacarìdeo, processo de preparação de oligossacarìdeos, e, utilização de oligossacarìdeos
DE3261625D1 (en) Tricyclic thiazolyl oxamic acids and derivatives, process for their production, and therapeutic agents containing them
ATE72118T1 (de) Pharmazeutische zusammensetzung und verfahren zu ihrer herstellung.
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
Heitlinger et al. Transport of glucose polymer-derived glucose by rabbit jejunum
ATE106874T1 (de) Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES472528A1 (es) Procedimiento para la preparacion de derivados de benzosul- fonamida
CA2508238A1 (en) Reovirus for the treatment of neoplasia
DE3341760A1 (de) Arzneimittel mit einer phagocyten-kontrollwirkung
JPS61100517A (ja) 新規齲蝕用剤